Market updates and forecasts

从ForexMart获得最新经济新闻,包括金融市场,中央银行政策宣告,财务指标,和影响这个银行的其他相关新闻的更新.

免责声明:   ForexMart不提供投资建议,所提供的分析不应被解释为对未来结果的承诺。

In January Pfizer lost $40 billion of capitalization


二月, 02 2023
watermark Economic news

In January of this year, shares of the drug manufacturer Pfizer experienced the most impressive drop since June 2020. This indicates a decrease in demand for COVID-19 products from this manufacturer.


The company's shares fell by 14%, reducing the company's market value by $40 billion. In its report, the company presented weaker than previously expected forecasts for sales of vaccines and pills for coronavirus infection. At the same time, its shares ended yesterday with an increase of 1.4% on the background of a broader market rally.


Carter Gould, an analyst at the British financial conglomerate Barclays, who assigned Pfizer shares a "Recommended for retention" rating, said that many expected the company's earnings per share to be below consensus. 


«Given the decline in stocks this month, there was hope for their recovery, but we are skeptical that this will happen in the near future,» Gould shared his thoughts. 


Pfizer's stock grew well during the pandemic in 2020-2021, as its vaccine and pills from COVID-19 brought the company billions of dollars in sales revenue.


反馈

ForexMart is authorized and regulated in various jurisdictions.

(Reg No.23071, IBC 2015) with a registered office at Shamrock Lodge, Murray Road, Kingstown, Saint Vincent and the Grenadines

Restricted Regions: the United States of America, North Korea, Sudan, Syria and some other regions.


© 2015-2024 Tradomart SV Ltd.
Top Top
风险提示:
外汇本质上有高度的投机性和复杂性,可能并不适合所有投资者。 外汇交易可能会带来重大的收益或损失。 因此,建议您不要承担无法承受的损失。 在使用ForexMart提供的服务之前,请确认外汇交易相关联的风险。 必要时寻求独立的财务意见。请注意,过去的业绩和预测都不是未来结果的可靠指标。
外汇本质上有高度的投机性和复杂性,可能并不适合所有投资者。 外汇交易可能会带来重大的收益或损失。 因此,建议您不要承担无法承受的损失。 在使用ForexMart提供的服务之前,请确认外汇交易相关联的风险。 必要时寻求独立的财务意见。请注意,过去的业绩和预测都不是未来结果的可靠指标。